Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Dopa decarboxylase gene polymorphisms and attention deficit hyperactivity disorder (ADHD): no evidence for association in the Irish population
2001
Itraconazole Prophylaxis in Lung Transplant Recipients Receiving Tacrolimus (FK 506): Efficacy and Drug Interaction
2005
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
2007 Standout
Treatment of Attention-Deficit–Hyperactivity Disorder
1999
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.
1997 Standout
Inhibition of Cytochromes P450 by Antifungal Imidazole Derivatives
2002
Clinical Aspects of Fungal Infection in Organ Transplant Recipients
1994
A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder
2001
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
Does Maternal ADHD Reduce the Effectiveness of Parent Training for Preschool Children's ADHD?
2002
Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder
2004
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
Adverse Drug Reactions to Systemic Antifungals Prevention and Management
1992
Drug Interactions of Clinical Significance with Selective Serotonin Reuptake Inhibitors
1997
Coccidioidomycosis in Solid Organ Transplantation
2001
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Drug Interactions with Tobacco Smoking
1999
Effects of Methylphenidate on Attention and Nonverbal Learning in Children With Attention-Deficit Hyperactivity Disorder
1997
Oral Anticoagulant Therapy
2012 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Antifungal Agents. Part II. The Azoles
1999
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
A Double-blind, Crossover Comparison of Methylphenidate and Placebo in Adults With Childhood-Onset Attention-Deficit Hyperactivity Disorder
1995
Relation of Demographic and Lifestyle Factors to Symptoms in a Multi-Racial/Ethnic Population of Women 40-55 Years of Age
2000 Standout
Porphyrias
2010 Standout
Management of Cryptococcal Meningitis in Sub-Saharan Africa
2010
A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder
2005
Symptomatic Relapse of HIV‐Associated Cryptococcal Meningitis after Initial Fluconazole Monotherapy: The Role of Fluconazole Resistance and Immune Reconstitution
2006
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
2016 Standout
Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction
2010
Coccidioidomycosis in liver transplantation
2005
Fluconazole Compared with Ketoconazole for the Treatment of Candida Esophagitis in AIDS
1992
Executive Functions and Developmental Psychopathology
1996 Standout
Upgrading the Science and Technology of Assessment and Diagnosis: Laboratory and Clinic-Based Assessment of Children With ADHD
2000
Pharmacokinetics and Pharmacodynamics of Systemically Administered Glucocorticoids
2005
Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole
1994
Factors Influencing the Magnitude and Clinical Significance of Drug Interactions Between Azole Antifungals and Select Immunosuppressants
2006
The Serotonin Syndrome
2005 Standout
Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses
1997
Refractory Mucosal Candidiasis in Patients with Human Immunodeficiency Virus Infection
1998
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Structural Basis for the Antibiotic Activity of Ketolides and Azalides
2003 StandoutNobel
Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
1997
Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient?
1988
Considerations in choice of a clinical endpoint for AIDS clinical trials
1994
Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT1B receptor gene in 273 nuclear families from a multi-centre sample
2002
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism
1998
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Coccidioidomycosis in Liver Transplant Recipients Relocating to an Endemic Area
2004
The ecological validity of laboratory and analogue assessment methods of ADHD symptoms
1991
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
Psychiatric Aspects of Impulsivity
2001 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Ribosomal antibiotics: structural basis for resistance, synergism and selectivity
2004 StandoutNobel
Fluconazole Bioequivalence Study: Quantification by Tandem Mass Spectrometry
1999
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The Current State of Knowledge on Age, Sex, and Their Interactions on Clinical Pharmacology
2007
Topographic diversity of fungal and bacterial communities in human skin
2013 StandoutNature
Computerized Training of Working Memory in Children With ADHD-A Randomized, Controlled Trial
2005 Standout
Fluconazole Therapy for Histoplasmosis
1996
Smoking and recurrent attacks of acute intermittent porphyria.
1991
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Fluconazole
1995
A Mechanistic Approach to Antiepileptic Drug Interactions
1998
The Macrolides: Erythromycin, Clarithromycin, and Azithromycin
1999
Azole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.
2002 Standout
Observations of parent-child interactions with hyperactive children: Research and clinical implications
1991
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Pharmacotherapy of Attention Deficit Hyperactivity Disorder
2000
Zygomycetes in Human Disease
2000 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Sex determination and sex differentiation in fish: an overview of genetic, physiological, and environmental influences
2002 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
2007 Standout
Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
2019
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Increased 2-Hydroxylation of Estradiol as a Possible Mechanism for the Anti-Estrogenic Effect of Cigarette Smoking
1986
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 α-ethinyloestradiol. Relative activities of rat and human liver enzymes
1990
Practice Parameters for the Assessment and Treatment of Children, Adolescents, and Adults With Attention-Deficit/Hyperactivity Disorder
1997
Systemic Antifungal Agents
1998
Direct Renin Inhibitors as a New Therapy for Hypertension
2010
Physicochemical and drug-delivery considerations for oral drug bioavailability
1996
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
ANTIBIOTICS TARGETING RIBOSOMES: Resistance, Selectivity, Synergism, and Cellular Regulation
2005 StandoutNobel
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population
2005 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Effects of single doses of alcohol and caffeine on cigarette smoke puffing behavior
1984
Hidden Killers: Human Fungal Infections
2012 Standout
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Association of attention-deficit disorder and the dopamine transporter gene.
1995
Molecular Genetics of Attention-Deficit/Hyperactivity Disorder
2005 Standout
Works of Mark Gardner being referenced
Induction of Fluconazole Metabolism by Rifampin: In Vivo Study in Humans
1991
Attention Deficit Disorder and Methylphenidate: Normalization Rates, Clinical Effectiveness, and Response Prediction in 76 Children
1994
INTERACTION BETWEEN CYCLOSPORINE AND FLUCONAZOLE IN RENAL ALLOGRAFT RECIPIENTS
1991
Effect of fluconazole on the disposition of phenytoin
1991
Oral Administration of Nano-Emulsion Curcumin in Mice Suppresses Inflammatory-Induced NFκB Signaling and Macrophage Migration
2014
Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking
1988
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene
2006
Increased Gastric pH and the Bioavailability of Fluconazole and Ketoconazole
1991
Effect of Sertraline on the Pharmacokinetics and Protein Binding of Diazepam in Healthy Volunteers
1997
Discovery of Inhibitors of Human Renin with High Oral Bioavailability
1995
Enhanced biotransformation of theophylline in marihuana and tobacco smokers
1978
Cimetidine-methylprednisolone-theophylline metabolic interaction
1984
Pharmacokinetics of fluconazole in renal failure.
1995
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension
1993
Attention Deficit Disorder and Methylphenidate: Group and Single-Subject Analyses of Dose Effects on Attention in Clinic and Classroom Settings
1987
Factors affecting theophylline clearances: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol
1979